Fetal growth in PCOS pregnancies: dynamic evidence of restriction and the modifying role of ART

• by Heze Xu, Yijia Liu, Xinyi Bian, Zhijiao Wang, Zhen Li, Hang Zhen, Shanwei Xing, Jingshuang Zhou, Zekai Bai, Jiapo Li, Chong Qiao

• July 15, 2026

Orchestrating the gut microbiota–mitochondrial–immune axis in gynecological diseases: mechanisms and dual-targeting therapeutic strategies

• by Haixia Tang, Yiting Zhang, Yanting Wang, Ze Zhou, Rong Sun, Rong Chen, Lijuan Yang, Mengqiu Shao, Jiabao Liao

• July 1, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

High serum FSH levels on day 7 of stimulation are negatively associated with oocyte retrieval in GnRH antagonist protocols: real-world evidence from 9,969 IVF cycles in China

• by Xiu Luo, Hong Ye, Li Pei, Yao He, Fujie Li, Wei Han, Shun Xiong, Shubiao Han, Jingyu Li, Xiaodong Zhang, Guoning Huang

• May 5, 2026